

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular potassium ion homeostasis (GO:0030007) | 9.81937141 |
| 2 | response to lipoprotein particle (GO:0055094) | 9.56052578 |
| 3 | cellular response to vitamin D (GO:0071305) | 9.28107649 |
| 4 | phosphate ion homeostasis (GO:0055062) | 8.49812981 |
| 5 | trivalent inorganic anion homeostasis (GO:0072506) | 8.49812981 |
| 6 | response to lead ion (GO:0010288) | 8.46797349 |
| 7 | virion attachment to host cell (GO:0019062) | 8.45047177 |
| 8 | adhesion of symbiont to host cell (GO:0044650) | 8.45047177 |
| 9 | cellular anion homeostasis (GO:0030002) | 7.94380278 |
| 10 | relaxation of cardiac muscle (GO:0055119) | 7.69438146 |
| 11 | response to vitamin D (GO:0033280) | 7.62181330 |
| 12 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 7.49189381 |
| 13 | response to hepatocyte growth factor (GO:0035728) | 7.49189381 |
| 14 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 7.46842823 |
| 15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 6.77583756 |
| 16 | membrane repolarization (GO:0086009) | 6.77562995 |
| 17 | adhesion of symbiont to host (GO:0044406) | 6.64579711 |
| 18 | positive regulation of glycogen biosynthetic process (GO:0045725) | 6.55659810 |
| 19 | negative regulation of activin receptor signaling pathway (GO:0032926) | 6.51175635 |
| 20 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 6.41124430 |
| 21 | hemidesmosome assembly (GO:0031581) | 6.40852443 |
| 22 | collecting duct development (GO:0072044) | 6.37155749 |
| 23 | neural tube formation (GO:0001841) | 6.14492431 |
| 24 | cellular sodium ion homeostasis (GO:0006883) | 6.10712759 |
| 25 | cellular response to interferon-alpha (GO:0035457) | 6.07466976 |
| 26 | cell communication by electrical coupling (GO:0010644) | 5.88134427 |
| 27 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.84950571 |
| 28 | potassium ion import (GO:0010107) | 5.84543494 |
| 29 | positive regulation of glycogen metabolic process (GO:0070875) | 5.73648847 |
| 30 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 5.73453745 |
| 31 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 5.73453745 |
| 32 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.65820599 |
| 33 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 5.44432370 |
| 34 | potassium ion homeostasis (GO:0055075) | 5.32155073 |
| 35 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 5.25273390 |
| 36 | chemosensory behavior (GO:0007635) | 5.05432014 |
| 37 | relaxation of muscle (GO:0090075) | 4.98314396 |
| 38 | detection of calcium ion (GO:0005513) | 4.81251367 |
| 39 | positive regulation of glucose import (GO:0046326) | 4.78629795 |
| 40 | skin morphogenesis (GO:0043589) | 4.77161262 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.76983495 |
| 42 | desmosome organization (GO:0002934) | 4.72529604 |
| 43 | negative regulation of fibroblast apoptotic process (GO:2000270) | 4.58039572 |
| 44 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.52777416 |
| 45 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 4.46642150 |
| 46 | negative regulation of microtubule polymerization (GO:0031115) | 4.46412012 |
| 47 | bone resorption (GO:0045453) | 4.45763663 |
| 48 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.42854319 |
| 49 | regulation of cardioblast proliferation (GO:0003264) | 4.42582485 |
| 50 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.42582485 |
| 51 | cell communication involved in cardiac conduction (GO:0086065) | 4.37761217 |
| 52 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.37354840 |
| 53 | cellular response to vitamin (GO:0071295) | 4.34552784 |
| 54 | response to interferon-alpha (GO:0035455) | 4.27491874 |
| 55 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.14948787 |
| 56 | middle ear morphogenesis (GO:0042474) | 4.11733723 |
| 57 | positive regulation of calcium ion import (GO:0090280) | 4.05942956 |
| 58 | epithelial cell fate commitment (GO:0072148) | 4.05799533 |
| 59 | regulation of glomerular filtration (GO:0003093) | 4.03318017 |
| 60 | cranial nerve morphogenesis (GO:0021602) | 4.02941920 |
| 61 | short-term memory (GO:0007614) | 4.01389695 |
| 62 | response to ischemia (GO:0002931) | 3.97563591 |
| 63 | positive regulation of glucose transport (GO:0010828) | 3.91797136 |
| 64 | positive regulation of ATP catabolic process (GO:1903291) | 3.90412482 |
| 65 | positive regulation of ATPase activity (GO:0032781) | 3.90412482 |
| 66 | regulation of somitogenesis (GO:0014807) | 3.88747852 |
| 67 | * thymus development (GO:0048538) | 3.87923558 |
| 68 | myelin maintenance (GO:0043217) | 3.86036204 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.84799482 |
| 70 | regulation of macrophage chemotaxis (GO:0010758) | 3.83207411 |
| 71 | regulation of glucan biosynthetic process (GO:0010962) | 3.82323583 |
| 72 | regulation of glycogen biosynthetic process (GO:0005979) | 3.82323583 |
| 73 | regulation of cellular extravasation (GO:0002691) | 3.80722876 |
| 74 | extracellular matrix assembly (GO:0085029) | 3.74229993 |
| 75 | outer ear morphogenesis (GO:0042473) | 3.73780888 |
| 76 | positive regulation of bone mineralization (GO:0030501) | 3.69827239 |
| 77 | activation of MAPKKK activity (GO:0000185) | 3.68578435 |
| 78 | phosphatidylinositol dephosphorylation (GO:0046856) | 3.68461048 |
| 79 | mesenchymal cell differentiation (GO:0048762) | 3.67802762 |
| 80 | regulation of mononuclear cell migration (GO:0071675) | 3.66837611 |
| 81 | cAMP metabolic process (GO:0046058) | 3.64327428 |
| 82 | proline transport (GO:0015824) | 3.63798016 |
| 83 | cytokine production involved in immune response (GO:0002367) | 3.63163044 |
| 84 | cell differentiation involved in metanephros development (GO:0072202) | 3.62109097 |
| 85 | negative regulation of osteoblast proliferation (GO:0033689) | 3.59524132 |
| 86 | positive regulation of embryonic development (GO:0040019) | 3.59265564 |
| 87 | embryonic epithelial tube formation (GO:0001838) | 3.59031189 |
| 88 | metanephric mesenchyme development (GO:0072075) | 3.58203163 |
| 89 | negative regulation of T cell apoptotic process (GO:0070233) | 3.57152609 |
| 90 | hair follicle development (GO:0001942) | 3.56890252 |
| 91 | positive regulation of biomineral tissue development (GO:0070169) | 3.56193603 |
| 92 | lateral sprouting from an epithelium (GO:0060601) | 3.54914716 |
| 93 | cellular response to nutrient (GO:0031670) | 3.53711803 |
| 94 | regulation of natural killer cell differentiation (GO:0032823) | 3.53044247 |
| 95 | embryonic cranial skeleton morphogenesis (GO:0048701) | 3.52644804 |
| 96 | positive regulation of p38MAPK cascade (GO:1900745) | 3.51975863 |
| 97 | polyol biosynthetic process (GO:0046173) | 3.48777583 |
| 98 | regulation of hippo signaling (GO:0035330) | 3.48034142 |
| 99 | positive regulation of glucose metabolic process (GO:0010907) | 3.47746005 |
| 100 | ganglion development (GO:0061548) | 3.46743381 |
| 101 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.45804323 |
| 102 | regulation of apoptotic cell clearance (GO:2000425) | 3.44678280 |
| 103 | phospholipid dephosphorylation (GO:0046839) | 3.42388255 |
| 104 | positive regulation of potassium ion transport (GO:0043268) | 3.39158316 |
| 105 | sodium ion homeostasis (GO:0055078) | 3.38719394 |
| 106 | epithelial tube formation (GO:0072175) | 3.38093597 |
| 107 | alanine transport (GO:0032328) | 3.32605322 |
| 108 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.32595734 |
| 109 | positive regulation of Rap GTPase activity (GO:0032854) | 3.30800858 |
| 110 | kidney mesenchyme development (GO:0072074) | 3.28915207 |
| 111 | inositol phosphate-mediated signaling (GO:0048016) | 3.28841118 |
| 112 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.28494764 |
| 113 | regulation of polysaccharide biosynthetic process (GO:0032885) | 3.28202766 |
| 114 | negative regulation of leukocyte apoptotic process (GO:2000107) | 3.27132974 |
| 115 | negative regulation of biomineral tissue development (GO:0070168) | 3.26036657 |
| 116 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.25462605 |
| 117 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.24129427 |
| 118 | epithelial cell morphogenesis (GO:0003382) | 3.22896451 |
| 119 | renal system process involved in regulation of blood volume (GO:0001977) | 3.20225905 |
| 120 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.17626930 |
| 121 | complement activation, alternative pathway (GO:0006957) | 3.15141993 |
| 122 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.14532389 |
| 123 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.14041843 |
| 124 | establishment of planar polarity (GO:0001736) | 3.08481123 |
| 125 | establishment of tissue polarity (GO:0007164) | 3.08481123 |
| 126 | muscle cell migration (GO:0014812) | 3.08386382 |
| 127 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.06620869 |
| 128 | positive regulation of sodium ion transport (GO:0010765) | 3.05899950 |
| 129 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.05436123 |
| 130 | regulation of glycogen metabolic process (GO:0070873) | 3.05174526 |
| 131 | myoblast migration (GO:0051451) | 3.03099722 |
| 132 | positive regulation of protein export from nucleus (GO:0046827) | 3.02768025 |
| 133 | regulation of Rap GTPase activity (GO:0032317) | 3.01129691 |
| 134 | gland morphogenesis (GO:0022612) | 3.00287422 |
| 135 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.98018099 |
| 136 | viral genome replication (GO:0019079) | 2.97334137 |
| 137 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96819742 |
| 138 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.96819742 |
| 139 | regulation of keratinocyte proliferation (GO:0010837) | 2.91194782 |
| 140 | behavioral response to nicotine (GO:0035095) | 2.90038866 |
| 141 | regulation of fibroblast apoptotic process (GO:2000269) | 2.89954610 |
| 142 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.85932017 |
| 143 | mesenchymal cell proliferation (GO:0010463) | 2.84001782 |
| 144 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.83276457 |
| 145 | lymphocyte homeostasis (GO:0002260) | 2.82183206 |
| 146 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.81466605 |
| 147 | axon extension involved in axon guidance (GO:0048846) | 2.81077361 |
| 148 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.81077361 |
| 149 | hair cycle process (GO:0022405) | 2.80757860 |
| 150 | molting cycle process (GO:0022404) | 2.80757860 |
| 151 | regulation of complement activation (GO:0030449) | 2.79890200 |
| 152 | cell proliferation involved in metanephros development (GO:0072203) | 2.78719214 |
| 153 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.77156589 |
| 154 | cell proliferation involved in kidney development (GO:0072111) | 2.76747188 |
| 155 | inositol phosphate metabolic process (GO:0043647) | 2.75771206 |
| 156 | regulation of p38MAPK cascade (GO:1900744) | 2.75368760 |
| 157 | mesenchymal to epithelial transition (GO:0060231) | 2.72477862 |
| 158 | regulation of cellular respiration (GO:0043457) | 2.71838657 |
| 159 | cell migration in hindbrain (GO:0021535) | 2.71645583 |
| 160 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.71580249 |
| 161 | regulation of polysaccharide metabolic process (GO:0032881) | 2.70263934 |
| 162 | regulation of ATPase activity (GO:0043462) | 2.69424792 |
| 163 | regulation of ATP catabolic process (GO:1903289) | 2.69424792 |
| 164 | semaphorin-plexin signaling pathway (GO:0071526) | 2.69256692 |
| 165 | receptor recycling (GO:0001881) | 2.68684723 |
| 166 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.68277232 |
| 167 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.68083776 |
| 168 | adipose tissue development (GO:0060612) | 2.67913278 |
| 169 | regulation of mesenchymal cell proliferation (GO:0010464) | 2.67420076 |
| 170 | skin development (GO:0043588) | 2.67364749 |
| 171 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.66859787 |
| 172 | lymphocyte chemotaxis (GO:0048247) | 2.66669367 |
| 173 | regulation of glucose import (GO:0046324) | 2.66574439 |
| 174 | cochlea morphogenesis (GO:0090103) | 2.66518091 |
| 175 | facial nerve structural organization (GO:0021612) | 2.66289752 |
| 176 | glycine transport (GO:0015816) | 2.66006911 |
| 177 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 2.65869720 |
| 178 | aorta morphogenesis (GO:0035909) | 2.64980333 |
| 179 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.64326783 |
| 180 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.64159521 |
| 181 | regulation of activin receptor signaling pathway (GO:0032925) | 2.62926147 |
| 182 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.62074093 |
| 183 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.61464664 |
| 184 | respiratory system process (GO:0003016) | 2.60323961 |
| 185 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.58494260 |
| 186 | regulation of interleukin-1 secretion (GO:0050704) | 2.56855961 |
| 187 | thymic T cell selection (GO:0045061) | 2.55652545 |
| 188 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.55455737 |
| 189 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.55176671 |
| 190 | non-canonical Wnt signaling pathway (GO:0035567) | 2.54350100 |
| 191 | production of molecular mediator of immune response (GO:0002440) | 2.54217198 |
| 192 | positive regulation of myoblast differentiation (GO:0045663) | 2.52352301 |
| 193 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.52211828 |
| 194 | response to parathyroid hormone (GO:0071107) | 12.0645213 |
| 195 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 11.3505301 |
| 196 | sodium ion export (GO:0071436) | 10.3859495 |
| 197 | membrane repolarization during action potential (GO:0086011) | 10.0311478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.97466359 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.31451332 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.06741473 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.02070216 |
| 5 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.80029240 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.66361051 |
| 7 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.65842057 |
| 8 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 2.63680904 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61253085 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61253085 |
| 11 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57235884 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52184836 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.43851069 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42148559 |
| 15 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.40606016 |
| 16 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.39695100 |
| 17 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.32630874 |
| 18 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31917977 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.18486804 |
| 20 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11856556 |
| 21 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.11259718 |
| 22 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.04289158 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02543430 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 11.0537416 |
| 25 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.97770812 |
| 26 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.94065296 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.93588775 |
| 28 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92853972 |
| 29 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92037060 |
| 30 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90888290 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90241441 |
| 32 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.86859316 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.85593625 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.84786796 |
| 35 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.80003888 |
| 36 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78771349 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78660059 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77703001 |
| 39 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.74523967 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65714779 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64252384 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63192472 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52859226 |
| 44 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.52252599 |
| 45 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51954374 |
| 46 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.46368717 |
| 47 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46016960 |
| 48 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.45564441 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44883471 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44312547 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43339595 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.43200937 |
| 53 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.42140783 |
| 54 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.38672763 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38292530 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38221487 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37923810 |
| 58 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.35722726 |
| 59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33752431 |
| 60 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31491290 |
| 61 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.30117885 |
| 62 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.29175600 |
| 63 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.29126006 |
| 64 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.28569093 |
| 65 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.28380313 |
| 66 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.27656878 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26763686 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26458200 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25953622 |
| 70 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.25633211 |
| 71 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25606575 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24008367 |
| 73 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23561297 |
| 74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21749933 |
| 75 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21453467 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21371569 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20715058 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20685881 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18473909 |
| 80 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17156440 |
| 81 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16986105 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16852035 |
| 83 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16086936 |
| 84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14211093 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13652947 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13345927 |
| 87 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.13291280 |
| 88 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13041936 |
| 89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.13011994 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.12818224 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12466472 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12142126 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10830901 |
| 94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10637869 |
| 95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10622880 |
| 96 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.09640836 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07830397 |
| 98 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07275272 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06698776 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06358263 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05995220 |
| 102 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05473466 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05311882 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03810893 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03206328 |
| 106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00768088 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00587452 |
| 108 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00056202 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99776909 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99041154 |
| 111 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98934719 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98326542 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98067447 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97945126 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97579652 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97519065 |
| 117 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97519065 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97414667 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96766530 |
| 120 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93112957 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92464877 |
| 122 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.92059784 |
| 123 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91551972 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91521989 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91251744 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90542205 |
| 127 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90149516 |
| 128 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87946535 |
| 129 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87713290 |
| 130 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.87490687 |
| 131 | AR_19668381_ChIP-Seq_PC3_Human | 0.87448917 |
| 132 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87307990 |
| 133 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.86694097 |
| 134 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83857169 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83583343 |
| 136 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82384532 |
| 137 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81887871 |
| 138 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81369364 |
| 139 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77121617 |
| 140 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.76492602 |
| 141 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76261169 |
| 142 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76261169 |
| 143 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.76132225 |
| 144 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.76069016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 7.17882165 |
| 2 | MP0002254_reproductive_system_inflammat | 7.10225775 |
| 3 | MP0002909_abnormal_adrenal_gland | 5.81738432 |
| 4 | MP0001346_abnormal_lacrimal_gland | 5.46730446 |
| 5 | MP0002098_abnormal_vibrissa_morphology | 2.89346272 |
| 6 | MP0003941_abnormal_skin_development | 2.89145388 |
| 7 | MP0010030_abnormal_orbit_morphology | 2.82486837 |
| 8 | MP0008789_abnormal_olfactory_epithelium | 2.67840086 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.67222684 |
| 10 | MP0000383_abnormal_hair_follicle | 2.60774172 |
| 11 | MP0000566_synostosis | 2.54681506 |
| 12 | MP0002234_abnormal_pharynx_morphology | 2.49142354 |
| 13 | MP0000762_abnormal_tongue_morphology | 2.36677920 |
| 14 | MP0003385_abnormal_body_wall | 2.20808390 |
| 15 | MP0000049_abnormal_middle_ear | 2.17807960 |
| 16 | MP0001849_ear_inflammation | 2.13972122 |
| 17 | MP0005623_abnormal_meninges_morphology | 2.10493433 |
| 18 | MP0001765_abnormal_ion_homeostasis | 2.08240941 |
| 19 | MP0005503_abnormal_tendon_morphology | 2.02867415 |
| 20 | MP0000467_abnormal_esophagus_morphology | 2.01676737 |
| 21 | MP0003755_abnormal_palate_morphology | 1.99991953 |
| 22 | MP0000685_abnormal_immune_system | 1.98872612 |
| 23 | MP0002177_abnormal_outer_ear | 1.98820805 |
| 24 | MP0009278_abnormal_bone_marrow | 1.98297479 |
| 25 | MP0001270_distended_abdomen | 1.95480187 |
| 26 | MP0002249_abnormal_larynx_morphology | 1.95265236 |
| 27 | MP0004484_altered_response_of | 1.93365276 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.92003872 |
| 29 | MP0010678_abnormal_skin_adnexa | 1.89880482 |
| 30 | MP0002168_other_aberrant_phenotype | 1.88991891 |
| 31 | MP0002233_abnormal_nose_morphology | 1.88965137 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.85923585 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.84891817 |
| 34 | * MP0009250_abnormal_appendicular_skeleto | 1.83944831 |
| 35 | MP0000579_abnormal_nail_morphology | 1.79921728 |
| 36 | MP0001958_emphysema | 1.76374190 |
| 37 | MP0000613_abnormal_salivary_gland | 1.75110497 |
| 38 | MP0002108_abnormal_muscle_morphology | 1.73123101 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.72078574 |
| 40 | MP0003937_abnormal_limbs/digits/tail_de | 1.67810657 |
| 41 | MP0003942_abnormal_urinary_system | 1.66144269 |
| 42 | MP0002896_abnormal_bone_mineralization | 1.65932793 |
| 43 | MP0000428_abnormal_craniofacial_morphol | 1.58493958 |
| 44 | MP0000681_abnormal_thyroid_gland | 1.57408655 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.56091835 |
| 46 | MP0003935_abnormal_craniofacial_develop | 1.55040274 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.44638303 |
| 48 | MP0000538_abnormal_urinary_bladder | 1.43121008 |
| 49 | MP0001340_abnormal_eyelid_morphology | 1.42999257 |
| 50 | MP0005023_abnormal_wound_healing | 1.38919594 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.35716279 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.35375161 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.30182999 |
| 54 | * MP0002116_abnormal_craniofacial_bone | 1.29578485 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.28156656 |
| 56 | MP0005248_abnormal_Harderian_gland | 1.27048630 |
| 57 | * MP0002932_abnormal_joint_morphology | 1.25771198 |
| 58 | MP0005671_abnormal_response_to | 1.23706313 |
| 59 | * MP0002938_white_spotting | 1.23305556 |
| 60 | MP0005394_taste/olfaction_phenotype | 1.22887228 |
| 61 | MP0005499_abnormal_olfactory_system | 1.22887228 |
| 62 | MP0001293_anophthalmia | 1.20242035 |
| 63 | MP0000377_abnormal_hair_follicle | 1.18771660 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 1.17500565 |
| 65 | MP0000462_abnormal_digestive_system | 1.15770744 |
| 66 | MP0004272_abnormal_basement_membrane | 1.15467633 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.14520637 |
| 68 | MP0008260_abnormal_autophagy | 1.13640700 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.12346230 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.12173492 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.07964250 |
| 72 | MP0003724_increased_susceptibility_to | 1.07723990 |
| 73 | * MP0005508_abnormal_skeleton_morphology | 1.06863391 |
| 74 | MP0001835_abnormal_antigen_presentation | 1.06773895 |
| 75 | MP0003950_abnormal_plasma_membrane | 1.05809082 |
| 76 | MP0005310_abnormal_salivary_gland | 1.03830291 |
| 77 | MP0000647_abnormal_sebaceous_gland | 1.02798669 |
| 78 | * MP0002109_abnormal_limb_morphology | 1.01052375 |
| 79 | MP0002102_abnormal_ear_morphology | 1.00450205 |
| 80 | MP0003938_abnormal_ear_development | 1.00350306 |
| 81 | * MP0000163_abnormal_cartilage_morphology | 0.99092465 |
| 82 | * MP0000516_abnormal_urinary_system | 0.98707233 |
| 83 | * MP0005367_renal/urinary_system_phenotyp | 0.98707233 |
| 84 | MP0000427_abnormal_hair_cycle | 0.98419456 |
| 85 | MP0000026_abnormal_inner_ear | 0.97447447 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.96197652 |
| 87 | MP0000858_altered_metastatic_potential | 0.95603392 |
| 88 | MP0000432_abnormal_head_morphology | 0.92960710 |
| 89 | MP0005395_other_phenotype | 0.92324484 |
| 90 | MP0001299_abnormal_eye_distance/ | 0.91875909 |
| 91 | MP0002060_abnormal_skin_morphology | 0.90714430 |
| 92 | MP0003283_abnormal_digestive_organ | 0.90224817 |
| 93 | MP0005387_immune_system_phenotype | 0.89530182 |
| 94 | MP0001790_abnormal_immune_system | 0.89530182 |
| 95 | MP0002092_abnormal_eye_morphology | 0.89017434 |
| 96 | MP0004510_myositis | 0.88672079 |
| 97 | MP0002697_abnormal_eye_size | 0.87217730 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.87180373 |
| 99 | * MP0002115_abnormal_skeleton_extremities | 0.85292476 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.82873971 |
| 101 | MP0003303_peritoneal_inflammation | 0.81831517 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.80102345 |
| 103 | MP0005166_decreased_susceptibility_to | 0.79448105 |
| 104 | MP0001851_eye_inflammation | 0.79245943 |
| 105 | MP0001177_atelectasis | 0.79200166 |
| 106 | MP0001485_abnormal_pinna_reflex | 0.78486774 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.78454618 |
| 108 | MP0002796_impaired_skin_barrier | 0.78236344 |
| 109 | MP0005171_absent_coat_pigmentation | 0.75759669 |
| 110 | * MP0002111_abnormal_tail_morphology | 0.75224797 |
| 111 | MP0006072_abnormal_retinal_apoptosis | 0.74693863 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.73749688 |
| 113 | MP0004858_abnormal_nervous_system | 0.73359087 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.72203395 |
| 115 | MP0001286_abnormal_eye_development | 0.70710084 |
| 116 | * MP0002114_abnormal_axial_skeleton | 0.70154427 |
| 117 | MP0002282_abnormal_trachea_morphology | 0.68347178 |
| 118 | * MP0000733_abnormal_muscle_development | 0.67574493 |
| 119 | MP0005165_increased_susceptibility_to | 0.67352020 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.66161244 |
| 121 | MP0003136_yellow_coat_color | 0.65977757 |
| 122 | MP0003633_abnormal_nervous_system | 0.65951056 |
| 123 | * MP0002113_abnormal_skeleton_development | 0.65363061 |
| 124 | MP0000470_abnormal_stomach_morphology | 0.64721838 |
| 125 | MP0005193_abnormal_anterior_eye | 0.64603419 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.64560480 |
| 127 | MP0009764_decreased_sensitivity_to | 0.62905154 |
| 128 | MP0005501_abnormal_skin_physiology | 0.62828595 |
| 129 | MP0002184_abnormal_innervation | 0.62578515 |
| 130 | MP0004134_abnormal_chest_morphology | 0.62506484 |
| 131 | MP0004084_abnormal_cardiac_muscle | 0.59265080 |
| 132 | * MP0005390_skeleton_phenotype | 0.58910061 |
| 133 | MP0003786_premature_aging | 0.58693976 |
| 134 | MP0008004_abnormal_stomach_pH | 0.58372875 |
| 135 | MP0003436_decreased_susceptibility_to | 0.57229764 |
| 136 | MP0003566_abnormal_cell_adhesion | 0.55837009 |
| 137 | MP0005275_abnormal_skin_tensile | 0.54889259 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.53683371 |
| 139 | * MP0003795_abnormal_bone_structure | 0.53400448 |
| 140 | MP0005666_abnormal_adipose_tissue | 0.53079487 |
| 141 | MP0009840_abnormal_foam_cell | 0.52346132 |
| 142 | MP0002736_abnormal_nociception_after | 0.50374565 |
| 143 | MP0002972_abnormal_cardiac_muscle | 0.49781987 |
| 144 | MP0005620_abnormal_muscle_contractility | 0.49615833 |
| 145 | MP0003186_abnormal_redox_activity | 0.48533476 |
| 146 | MP0010234_abnormal_vibrissa_follicle | 0.45290937 |
| 147 | MP0001968_abnormal_touch/_nociception | 0.43423238 |
| 148 | MP0008775_abnormal_heart_ventricle | 0.43035407 |
| 149 | MP0001963_abnormal_hearing_physiology | 0.39840953 |
| 150 | MP0003137_abnormal_impulse_conducting | 0.38862450 |
| 151 | MP0003646_muscle_fatigue | 0.37685431 |
| 152 | MP0001486_abnormal_startle_reflex | 0.37422587 |
| 153 | MP0001915_intracranial_hemorrhage | 0.36526734 |
| 154 | MP0001191_abnormal_skin_condition | 0.32904455 |
| 155 | MP0003631_nervous_system_phenotype | 0.31768824 |
| 156 | MP0002063_abnormal_learning/memory/cond | 0.31728048 |
| 157 | MP0004036_abnormal_muscle_relaxation | 0.31603622 |
| 158 | MP0003953_abnormal_hormone_level | 0.31246388 |
| 159 | MP0002653_abnormal_ependyma_morphology | 0.30496117 |
| 160 | MP0004947_skin_inflammation | 0.30114116 |
| 161 | MP0004381_abnormal_hair_follicle | 0.29831217 |
| 162 | MP0003879_abnormal_hair_cell | 0.29287677 |
| 163 | MP0002295_abnormal_pulmonary_circulatio | 0.28262352 |
| 164 | MP0000778_abnormal_nervous_system | 0.27755733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 9.58469837 |
| 2 | Hypoparathyroidism (HP:0000829) | 9.00319456 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.64207637 |
| 4 | Increased circulating renin level (HP:0000848) | 7.12840458 |
| 5 | Hypocalcemia (HP:0002901) | 6.63154719 |
| 6 | Onycholysis (HP:0001806) | 6.08237292 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 6.00858146 |
| 8 | Milia (HP:0001056) | 5.88558547 |
| 9 | Metaphyseal irregularity (HP:0003025) | 5.25464626 |
| 10 | Atrophic scars (HP:0001075) | 5.20788680 |
| 11 | J-shaped sella turcica (HP:0002680) | 5.15899546 |
| 12 | Fragile nails (HP:0001808) | 5.11680714 |
| 13 | Conjugated hyperbilirubinemia (HP:0002908) | 5.03565312 |
| 14 | Lip pit (HP:0100267) | 4.83293102 |
| 15 | Aplasia cutis congenita (HP:0001057) | 4.71853085 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 4.50891201 |
| 17 | Selective tooth agenesis (HP:0001592) | 4.11434497 |
| 18 | Plantar hyperkeratosis (HP:0007556) | 4.11162751 |
| 19 | Hyperparathyroidism (HP:0000843) | 4.05382496 |
| 20 | Natal tooth (HP:0000695) | 3.98590642 |
| 21 | Polydipsia (HP:0001959) | 3.70133264 |
| 22 | Abnormal drinking behavior (HP:0030082) | 3.70133264 |
| 23 | Chronic otitis media (HP:0000389) | 3.67810456 |
| 24 | Hypomagnesemia (HP:0002917) | 3.55630418 |
| 25 | Morphological abnormality of the middle ear (HP:0008609) | 3.53541460 |
| 26 | * Abnormality of the lacrimal duct (HP:0011481) | 3.47246797 |
| 27 | * Abnormality of the nasolacrimal system (HP:0000614) | 3.40875384 |
| 28 | Absent eyebrow (HP:0002223) | 3.30664284 |
| 29 | Pili torti (HP:0003777) | 3.30118588 |
| 30 | Fair hair (HP:0002286) | 3.29203932 |
| 31 | Shallow orbits (HP:0000586) | 3.12887631 |
| 32 | Abnormality of renin-angiotensin system (HP:0000847) | 3.11805076 |
| 33 | Esophageal atresia (HP:0002032) | 3.11203022 |
| 34 | Abnormality of magnesium homeostasis (HP:0004921) | 3.03961685 |
| 35 | Deformed sella turcica (HP:0002681) | 3.02463510 |
| 36 | Cutaneous finger syndactyly (HP:0010554) | 2.91473697 |
| 37 | Midline defect of the nose (HP:0004122) | 2.89724442 |
| 38 | Advanced eruption of teeth (HP:0006288) | 2.88053410 |
| 39 | Generalized hypopigmentation of hair (HP:0011358) | 2.87952557 |
| 40 | Hypotrichosis (HP:0001006) | 2.87111676 |
| 41 | Unilateral renal agenesis (HP:0000122) | 2.85286928 |
| 42 | Absent eyelashes (HP:0000561) | 2.80956972 |
| 43 | Abnormality of the parietal bone (HP:0002696) | 2.80658545 |
| 44 | Increased IgE level (HP:0003212) | 2.79516298 |
| 45 | * Nasolacrimal duct obstruction (HP:0000579) | 2.76815538 |
| 46 | Exotropia (HP:0000577) | 2.74282303 |
| 47 | Abnormality of renal excretion (HP:0011036) | 2.68173834 |
| 48 | Basal ganglia calcification (HP:0002135) | 2.68146972 |
| 49 | Sex reversal (HP:0012245) | 2.67315366 |
| 50 | Abnormal sex determination (HP:0012244) | 2.67315366 |
| 51 | Tachypnea (HP:0002789) | 2.65874374 |
| 52 | Nail dystrophy (HP:0008404) | 2.65069960 |
| 53 | Hypoplasia of dental enamel (HP:0006297) | 2.63779839 |
| 54 | Polyuria (HP:0000103) | 2.60690744 |
| 55 | Woolly hair (HP:0002224) | 2.60415333 |
| 56 | Sparse scalp hair (HP:0002209) | 2.58852392 |
| 57 | Amelogenesis imperfecta (HP:0000705) | 2.54678806 |
| 58 | Gonadotropin excess (HP:0000837) | 2.44688380 |
| 59 | Cutaneous syndactyly (HP:0012725) | 2.42456216 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.39041139 |
| 61 | Hypokalemia (HP:0002900) | 2.38506880 |
| 62 | Oligodontia (HP:0000677) | 2.35185997 |
| 63 | Abnormality of the gastric mucosa (HP:0004295) | 2.33056081 |
| 64 | Pterygium (HP:0001059) | 2.29185112 |
| 65 | Fragile skin (HP:0001030) | 2.24764036 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24701578 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24701578 |
| 68 | Hypodontia (HP:0000668) | 2.22863396 |
| 69 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.20732691 |
| 70 | Short 4th metacarpal (HP:0010044) | 2.20732691 |
| 71 | Septo-optic dysplasia (HP:0100842) | 2.17761387 |
| 72 | Vascular calcification (HP:0004934) | 2.16310018 |
| 73 | Palmoplantar hyperkeratosis (HP:0000972) | 2.15911762 |
| 74 | Inability to walk (HP:0002540) | 2.14732662 |
| 75 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14169383 |
| 76 | Abnormality of permanent molar morphology (HP:0011071) | 2.13377663 |
| 77 | Abnormality of the dental root (HP:0006486) | 2.13377663 |
| 78 | Taurodontia (HP:0000679) | 2.13377663 |
| 79 | Abnormality of the sella turcica (HP:0002679) | 2.13078983 |
| 80 | Deep venous thrombosis (HP:0002625) | 2.12380849 |
| 81 | Abnormal urine output (HP:0012590) | 2.11831531 |
| 82 | Narrow nasal bridge (HP:0000446) | 2.11050746 |
| 83 | Menstrual irregularities (HP:0000858) | 2.11044745 |
| 84 | Focal motor seizures (HP:0011153) | 2.06193694 |
| 85 | Cupped ear (HP:0000378) | 2.05340786 |
| 86 | Ureteral stenosis (HP:0000071) | 2.05281695 |
| 87 | Thickened calvaria (HP:0002684) | 2.05055035 |
| 88 | Stomach cancer (HP:0012126) | 2.04805126 |
| 89 | Abnormality of molar (HP:0011077) | 2.04756669 |
| 90 | Abnormality of molar morphology (HP:0011070) | 2.04756669 |
| 91 | Microdontia (HP:0000691) | 2.04281465 |
| 92 | Palmar hyperkeratosis (HP:0010765) | 2.01733446 |
| 93 | Occipital encephalocele (HP:0002085) | 2.01137106 |
| 94 | Hypercalciuria (HP:0002150) | 2.00195067 |
| 95 | Tetany (HP:0001281) | 19.4409055 |
| 96 | Hyperphosphatemia (HP:0002905) | 18.0929586 |
| 97 | Athetosis (HP:0002305) | 1.98836870 |
| 98 | White forelock (HP:0002211) | 1.98700767 |
| 99 | Premature skin wrinkling (HP:0100678) | 1.98333169 |
| 100 | Hypoplastic labia majora (HP:0000059) | 1.98250503 |
| 101 | Abnormality of the axillary hair (HP:0100134) | 1.97570275 |
| 102 | Abnormality of secondary sexual hair (HP:0009888) | 1.97570275 |
| 103 | Nephrocalcinosis (HP:0000121) | 1.95908209 |
| 104 | Abnormal urine phosphate concentration (HP:0012599) | 1.95394007 |
| 105 | Abnormality of the dental pulp (HP:0006479) | 1.95024813 |
| 106 | Abnormality of incisor morphology (HP:0011063) | 1.95017785 |
| 107 | Abnormal hair laboratory examination (HP:0003328) | 1.91130593 |
| 108 | * Mixed hearing impairment (HP:0000410) | 1.89623692 |
| 109 | Ventricular fibrillation (HP:0001663) | 1.89612158 |
| 110 | Ulnar bowing (HP:0003031) | 1.88874055 |
| 111 | Ureteral obstruction (HP:0006000) | 1.87618588 |
| 112 | Cellular immunodeficiency (HP:0005374) | 1.87315278 |
| 113 | * Abnormality of the antihelix (HP:0009738) | 1.86937205 |
| 114 | Resting tremor (HP:0002322) | 1.85108510 |
| 115 | Cardiovascular calcification (HP:0011915) | 1.83636644 |
| 116 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83555943 |
| 117 | Absent hair (HP:0002298) | 1.82819107 |
| 118 | Abnormality of the nasal septum (HP:0000419) | 1.82419809 |
| 119 | Abnormality of potassium homeostasis (HP:0011042) | 1.80857784 |
| 120 | Conical tooth (HP:0000698) | 1.80130851 |
| 121 | Ectropion (HP:0000656) | 1.79890451 |
| 122 | Death in childhood (HP:0003819) | 1.79834553 |
| 123 | Hypophosphatemia (HP:0002148) | 1.79816766 |
| 124 | Anophthalmia (HP:0000528) | 1.78497648 |
| 125 | Everted lower lip vermilion (HP:0000232) | 1.78292530 |
| 126 | Aplasia involving bones of the extremities (HP:0009825) | 1.77465575 |
| 127 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.77465575 |
| 128 | Aplasia of the phalanges of the hand (HP:0009802) | 1.77465575 |
| 129 | Sparse eyelashes (HP:0000653) | 1.76766876 |
| 130 | Myelomeningocele (HP:0002475) | 1.75002767 |
| 131 | Bilateral microphthalmos (HP:0007633) | 1.74576539 |
| 132 | Asymmetry of the thorax (HP:0001555) | 1.74205445 |
| 133 | Xerostomia (HP:0000217) | 1.72790124 |
| 134 | Panhypogammaglobulinemia (HP:0003139) | 1.72693528 |
| 135 | Recurrent corneal erosions (HP:0000495) | 1.72594189 |
| 136 | Widely spaced teeth (HP:0000687) | 1.72145408 |
| 137 | Facial cleft (HP:0002006) | 1.72065362 |
| 138 | Abnormality of the labia majora (HP:0012881) | 1.72005466 |
| 139 | Micronodular cirrhosis (HP:0001413) | 1.72003634 |
| 140 | Distal lower limb muscle weakness (HP:0009053) | 1.71654658 |
| 141 | Protruding ear (HP:0000411) | 1.71294320 |
| 142 | Skull defect (HP:0001362) | 1.70395477 |
| 143 | Renal dysplasia (HP:0000110) | 1.69345791 |
| 144 | Gastrointestinal atresia (HP:0002589) | 1.68378088 |
| 145 | Abnormality of the 4th metacarpal (HP:0010012) | 1.68220090 |
| 146 | * Alacrima (HP:0000522) | 1.65399057 |
| 147 | * Periauricular skin pits (HP:0100277) | 1.64764256 |
| 148 | * Preauricular pit (HP:0004467) | 1.64764256 |
| 149 | Scanning speech (HP:0002168) | 1.63953323 |
| 150 | Patchy hypopigmentation of hair (HP:0011365) | 1.62442003 |
| 151 | * Atresia of the external auditory canal (HP:0000413) | 1.61626430 |
| 152 | Choanal stenosis (HP:0000452) | 1.61219312 |
| 153 | Premature loss of primary teeth (HP:0006323) | 1.60990798 |
| 154 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.60061615 |
| 155 | Dysmetric saccades (HP:0000641) | 1.56958601 |
| 156 | Congenital sensorineural hearing impairment (HP:0008527) | 1.53876340 |
| 157 | Hyperventilation (HP:0002883) | 1.50999675 |
| 158 | Aplastic anemia (HP:0001915) | 1.47271004 |
| 159 | Abnormality of intracranial pressure (HP:0012640) | 1.46241600 |
| 160 | Increased intracranial pressure (HP:0002516) | 1.46241600 |
| 161 | Hypercalcemia (HP:0003072) | 1.44178082 |
| 162 | Delayed eruption of teeth (HP:0000684) | 1.37898142 |
| 163 | Mesangial abnormality (HP:0001966) | 1.34794565 |
| 164 | Abnormality of the basal ganglia (HP:0002134) | 1.34032276 |
| 165 | Oral leukoplakia (HP:0002745) | 1.32964872 |
| 166 | Bundle branch block (HP:0011710) | 1.32772648 |
| 167 | Thin bony cortex (HP:0002753) | 1.28111033 |
| 168 | Abnormality of renal resorption (HP:0011038) | 1.24573946 |
| 169 | Enlarged epiphyses (HP:0010580) | 1.23480726 |
| 170 | Intrahepatic cholestasis (HP:0001406) | 1.21890468 |
| 171 | Tented upper lip vermilion (HP:0010804) | 1.19584526 |
| 172 | Hypotension (HP:0002615) | 1.18854514 |
| 173 | Rickets (HP:0002748) | 1.14853147 |
| 174 | Azoospermia (HP:0000027) | 1.14387723 |
| 175 | Pancreatitis (HP:0001733) | 1.12921247 |
| 176 | Hypoplasia of the iris (HP:0007676) | 1.12279477 |
| 177 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.11516054 |
| 178 | Abnormality of alanine metabolism (HP:0010916) | 1.08545033 |
| 179 | Hyperalaninemia (HP:0003348) | 1.08545033 |
| 180 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.08545033 |
| 181 | Genetic anticipation (HP:0003743) | 1.02311840 |
| 182 | Hypoproteinemia (HP:0003075) | 1.01157531 |
| 183 | Proximal tubulopathy (HP:0000114) | 1.01025385 |
| 184 | Intention tremor (HP:0002080) | 0.94394364 |
| 185 | Syncope (HP:0001279) | 0.93091298 |
| 186 | Central scotoma (HP:0000603) | 0.90605710 |
| 187 | Areflexia of lower limbs (HP:0002522) | 0.88963382 |
| 188 | Abnormal ciliary motility (HP:0012262) | 0.87789884 |
| 189 | Fibular aplasia (HP:0002990) | 0.85776339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 8.31058842 |
| 2 | PDK2 | 7.43085664 |
| 3 | MAPK15 | 7.11072139 |
| 4 | STK38 | 3.07890374 |
| 5 | TSSK6 | 3.06740434 |
| 6 | CASK | 3.06104937 |
| 7 | EPHA2 | 2.93977492 |
| 8 | LATS1 | 2.55707770 |
| 9 | EPHB2 | 2.33175363 |
| 10 | FGFR2 | 2.25820090 |
| 11 | RET | 2.13122629 |
| 12 | MKNK2 | 2.09858038 |
| 13 | PRKD3 | 2.09050423 |
| 14 | SMG1 | 2.03764271 |
| 15 | FGFR4 | 1.97636371 |
| 16 | EPHB1 | 1.97516239 |
| 17 | CDK3 | 1.92281375 |
| 18 | SIK1 | 1.88146284 |
| 19 | SIK3 | 1.85728455 |
| 20 | RPS6KB2 | 1.82998132 |
| 21 | FER | 1.74176543 |
| 22 | MAP3K12 | 1.66239114 |
| 23 | CDK8 | 1.66043920 |
| 24 | VRK1 | 1.62733588 |
| 25 | PRKCG | 1.60762771 |
| 26 | EPHA3 | 1.59062038 |
| 27 | MKNK1 | 1.57591667 |
| 28 | TNIK | 1.54136851 |
| 29 | BMPR1B | 1.51970665 |
| 30 | FRK | 1.45153349 |
| 31 | MAPK12 | 1.43883301 |
| 32 | BLK | 1.43560601 |
| 33 | TTN | 1.41440741 |
| 34 | ERBB2 | 1.40279181 |
| 35 | MAPK7 | 1.37891251 |
| 36 | TRIB3 | 1.33974803 |
| 37 | PINK1 | 1.32735986 |
| 38 | DMPK | 1.32697903 |
| 39 | MAP3K14 | 1.29951444 |
| 40 | AKT3 | 1.21766129 |
| 41 | TYK2 | 1.21595151 |
| 42 | NTRK2 | 1.20936014 |
| 43 | STK38L | 1.14747180 |
| 44 | BTK | 1.13995357 |
| 45 | PAK2 | 1.13419229 |
| 46 | CDC42BPA | 1.10369371 |
| 47 | EEF2K | 1.09979160 |
| 48 | RIPK1 | 1.09565010 |
| 49 | DYRK1A | 1.06831331 |
| 50 | MAP3K13 | 1.06636587 |
| 51 | PRPF4B | 1.03860604 |
| 52 | CSNK1A1 | 0.95493870 |
| 53 | PRKD2 | 0.93763849 |
| 54 | FGFR3 | 0.92658243 |
| 55 | JAK1 | 0.90460693 |
| 56 | TIE1 | 0.90420902 |
| 57 | IKBKE | 0.89417166 |
| 58 | MAPK4 | 0.89361442 |
| 59 | TGFBR1 | 0.89057714 |
| 60 | SGK2 | 0.88268114 |
| 61 | MAP2K2 | 0.87765227 |
| 62 | DDR2 | 0.87093025 |
| 63 | LATS2 | 0.87074381 |
| 64 | TNK2 | 0.86635826 |
| 65 | MAP3K1 | 0.86457416 |
| 66 | SGK3 | 0.86236656 |
| 67 | INSRR | 0.85855978 |
| 68 | PTK2 | 0.85572641 |
| 69 | PRKCH | 0.85117242 |
| 70 | CAMK2G | 0.83490167 |
| 71 | CLK1 | 0.83345203 |
| 72 | NTRK3 | 0.82494361 |
| 73 | HIPK2 | 0.81987316 |
| 74 | SIK2 | 0.80399134 |
| 75 | CAMK2B | 0.80055231 |
| 76 | MAPKAPK2 | 0.79420835 |
| 77 | ICK | 0.79256283 |
| 78 | YES1 | 0.78973253 |
| 79 | PIK3CA | 0.76497541 |
| 80 | PLK3 | 0.75114699 |
| 81 | LRRK2 | 0.72943921 |
| 82 | NEK6 | 0.71026825 |
| 83 | RIPK4 | 0.70734762 |
| 84 | SGK223 | 0.70665888 |
| 85 | SGK494 | 0.70665888 |
| 86 | MYLK | 0.68342630 |
| 87 | CAMK1 | 0.67628667 |
| 88 | CHUK | 0.66809370 |
| 89 | GRK1 | 0.65307570 |
| 90 | EIF2AK2 | 0.65290229 |
| 91 | JAK3 | 0.64649392 |
| 92 | AKT2 | 0.63963310 |
| 93 | KSR1 | 0.63143719 |
| 94 | PDPK1 | 0.62437018 |
| 95 | CSNK1A1L | 0.62026247 |
| 96 | PKN2 | 0.61563231 |
| 97 | MAPKAPK5 | 0.61457537 |
| 98 | MAPK13 | 0.61204026 |
| 99 | PRKCE | 0.60987929 |
| 100 | FES | 0.59574761 |
| 101 | TXK | 0.58854257 |
| 102 | STK3 | 0.58785479 |
| 103 | PTK6 | 0.56561819 |
| 104 | TGFBR2 | 0.56139433 |
| 105 | ROCK2 | 0.55626044 |
| 106 | CAMK4 | 0.55622976 |
| 107 | PDK1 | 0.54694589 |
| 108 | MAP3K7 | 0.54431863 |
| 109 | CAMK1G | 0.52790065 |
| 110 | LMTK2 | 0.52094802 |
| 111 | PRKD1 | 0.51790785 |
| 112 | ERBB3 | 0.50986780 |
| 113 | NUAK1 | 0.50662149 |
| 114 | STK39 | 0.48089259 |
| 115 | DYRK3 | 0.47390016 |
| 116 | MUSK | 0.46493870 |
| 117 | IRAK1 | 0.45055265 |
| 118 | MAP2K6 | 0.44852145 |
| 119 | ADRBK1 | 0.44289054 |
| 120 | NLK | 0.43040042 |
| 121 | MARK2 | 0.42834159 |
| 122 | ROCK1 | 0.42710549 |
| 123 | MST4 | 0.41507734 |
| 124 | CAMK2D | 0.41412577 |
| 125 | CAMK2A | 0.41142615 |
| 126 | ADRBK2 | 0.41088580 |
| 127 | STK24 | 0.40632303 |
| 128 | IKBKB | 0.40288776 |
| 129 | JAK2 | 0.40165820 |
| 130 | PRKCQ | 0.39800917 |
| 131 | ERN1 | 0.39392861 |
| 132 | ZAK | 0.38484333 |
| 133 | CSNK1D | 0.36036577 |
| 134 | MTOR | 0.35900249 |
| 135 | MAP3K6 | 0.34487509 |
| 136 | RPS6KA2 | 0.34364799 |
| 137 | MAP3K4 | 0.33971966 |
| 138 | PHKG1 | 0.33019521 |
| 139 | PHKG2 | 0.33019521 |
| 140 | SRPK1 | 0.32707331 |
| 141 | MAP2K1 | 0.32099139 |
| 142 | CSNK1G1 | 0.31598333 |
| 143 | SRC | 0.31129074 |
| 144 | ILK | 0.31066764 |
| 145 | PNCK | 0.30444845 |
| 146 | EPHA4 | 0.29675199 |
| 147 | PASK | 0.29199537 |
| 148 | MAP2K7 | 0.28915149 |
| 149 | PRKCI | 0.28830435 |
| 150 | GSK3A | 0.28507184 |
| 151 | PRKCB | 0.28025775 |
| 152 | PLK2 | 0.26965586 |
| 153 | ACVR1B | 0.24723123 |
| 154 | PKN1 | 0.24197770 |
| 155 | PRKAA1 | 0.22728315 |
| 156 | PAK6 | 0.20315054 |
| 157 | PTK2B | 0.19556360 |
| 158 | MAP3K5 | 0.19428085 |
| 159 | PDGFRA | 0.19111288 |
| 160 | STK11 | 0.17967822 |
| 161 | MAPK1 | 0.17788292 |
| 162 | PRKCA | 0.17100527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 6.11471755 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 4.45047641 |
| 3 | Gastric acid secretion_Homo sapiens_hsa04971 | 4.24916563 |
| 4 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 3.21723601 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.15262166 |
| 6 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.47702763 |
| 7 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.35945977 |
| 8 | Mineral absorption_Homo sapiens_hsa04978 | 2.29673247 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.28067412 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.26258265 |
| 11 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 2.17059636 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.09327206 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.06795483 |
| 14 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.04462282 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.97018808 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.95757121 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.95411569 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.93171443 |
| 19 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.93059102 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86940927 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.80883928 |
| 22 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.74367568 |
| 23 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.67029299 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65353978 |
| 25 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.45177986 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44239554 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43748782 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.42296666 |
| 29 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.41432115 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.35036495 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34491422 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33847390 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31778107 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.31651629 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30808887 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.29374399 |
| 37 | Melanoma_Homo sapiens_hsa05218 | 1.28611915 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.27665772 |
| 39 | Taste transduction_Homo sapiens_hsa04742 | 1.26514905 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26178468 |
| 41 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.25915671 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.25499657 |
| 43 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.23509518 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22489269 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.21971415 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20545904 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18732148 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17574214 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17097448 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16704715 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 1.16397956 |
| 52 | Focal adhesion_Homo sapiens_hsa04510 | 1.16217231 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14753555 |
| 54 | Tight junction_Homo sapiens_hsa04530 | 1.13979888 |
| 55 | Adherens junction_Homo sapiens_hsa04520 | 1.13908954 |
| 56 | Pathways in cancer_Homo sapiens_hsa05200 | 1.13614489 |
| 57 | Measles_Homo sapiens_hsa05162 | 1.11275708 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09801889 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 1.09447620 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09419165 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09152578 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 1.08245982 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 1.04974547 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.04186802 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02489805 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00360859 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99928376 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99232550 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94764368 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93921852 |
| 71 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93060520 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92754845 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91098113 |
| 74 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.89379614 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.87269392 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.86940253 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86123719 |
| 78 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83954647 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83610463 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.83180398 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.82860595 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82275261 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.81809707 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.80902317 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79277386 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79113725 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78512356 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78140695 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77928402 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77768210 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.77586569 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77456573 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.77345657 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77306900 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76593703 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.76434611 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.76431269 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76038737 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74973768 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.74738507 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73851438 |
| 102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73069723 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72726489 |
| 104 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72278937 |
| 105 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72264884 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72109487 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.71480541 |
| 108 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71289097 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71015140 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70879555 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.70755265 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70630986 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.70483230 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68450682 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.67960995 |
| 116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67492673 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.66710586 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66585865 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66229118 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65909304 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65686378 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65469288 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.63817401 |
| 124 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63613181 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63481811 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62005130 |
| 127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.61989434 |
| 128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61856332 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60003583 |
| 130 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59233045 |
| 131 | ABC transporters_Homo sapiens_hsa02010 | 0.59217685 |
| 132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58558000 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58429551 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.58130600 |
| 135 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57272040 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55552944 |
| 137 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55209653 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55057619 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.55045504 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54992568 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54872289 |
| 142 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54512068 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53928008 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52767659 |
| 145 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51985414 |
| 146 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49941487 |
| 147 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47880752 |
| 148 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.42811160 |
| 149 | Peroxisome_Homo sapiens_hsa04146 | 0.40074515 |
| 150 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.35717977 |
| 151 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35500813 |
| 152 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34738801 |
| 153 | Insulin resistance_Homo sapiens_hsa04931 | 0.33120045 |
| 154 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32788980 |
| 155 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.31517458 |
| 156 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.30127892 |
| 157 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29808801 |
| 158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29671451 |
| 159 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28993872 |
| 160 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28817183 |
| 161 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28339588 |
| 162 | Endocytosis_Homo sapiens_hsa04144 | 0.25981274 |
| 163 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23970791 |
| 164 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23191871 |
| 165 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21806728 |
| 166 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16461458 |
| 167 | Apoptosis_Homo sapiens_hsa04210 | 0.16054207 |

